Viusid in Adults With Acute Fever of Viral Etiology

• Status: Completed
• Trial end date: 2010-05-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of the study is to assess the safety and effect of Viusid (bags of 4 grams) administration in the treatment of acute fever of viral etiology as diagnosed by clinical, hematologic and serologic parameters. The duration of this open and randomized phase 2 clinical trial will be 6 days. The estimated number of persons with acute fever of viral etiology to be recruited and randomized for the study is 200. The primary outcome measure: platelet, leukocyte and granulocyte count will be assessed at the beginning and the end of the study.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Catalysis SL

Criteria

Inclusion Criteria:

• Acute fever of viral etiology with less than 72 hours of progression

• Signed informed consent.

Exclusion Criteria:

• Patients under treatment with other antioxidants.

• Inability to swallow the content of Viusid bags